SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-138506
Filing Date
2021-11-15
Accepted
2021-11-15 07:01:24
Documents
12
Period of Report
2021-11-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2132865d1_8k.htm   iXBRL 8-K 23816
  Complete submission text file 0001104659-21-138506.txt   197379

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mrkr-20211110.xsd EX-101.SCH 3192
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrkr-20211110_lab.xml EX-101.LAB 34594
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrkr-20211110_pre.xml EX-101.PRE 22715
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2132865d1_8k_htm.xml XML 3615
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37939 | Film No.: 211406241
SIC: 2834 Pharmaceutical Preparations